STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Tevogen Bio Holdings Inc.

Filed

December 22, 2025

Period of Report

December 18, 2025

Accession Number

0001123292-25-000765